Month: June 2020

Sales decline 28.86% to Rs 100.12 crore. Net profit of Caplin Point Laboratories rose 24.38% to Rs 50.15 crore in the quarter ended March 2020 as against Rs 40.32 crore during the previous quarter ended March 2019. Sales declined 28.86% to Rs 100.12 crore in the quarter ended March 2020 as against Rs 140.74 crore…

Read More »

Caplin Point Laboratories jumped 6% to Rs 374 after the drug maker received the final approval from the US drug regulator for its Abbreviated New Drug Application (ANDA) Phenylephrine Hydrochloride injection. Phenylephrine Hydrochloride injection is indicated for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia. The drug had…

Read More »